Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Recruiting
Who can join
Ages 5 to 14 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosed with a mood and/or anxiety disorder * Have proficiency to participate in psychotherapy in English * Scheduled to begin therapy at one of the study sites * RCADS score \> 65 Exclusion Criteria: \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
About the study
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
What is being tested
- Teleo (other)
- Standard Videoconferencing (other)
Sponsor: Stanford University · Participants: 156 · Started: Jun 24, 2026
Contact the study team
- Jesse A Barrera, BA · Phone: 6193792399
- David S Hong, MD · Phone: (650) 723-5511
Official record on ClinicalTrials.gov — NCT07155707
Locations in the U.S.
| California | Ohana Center for Child and Adolescent Behavioral Health, Monterey (Not yet recruiting) Stanford University, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.